Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:1128-1134

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bienvenu, J.-G.
Right arrow Articles by Merhi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bienvenu, J.-G.
Right arrow Articles by Merhi, Y.
Related Collections
Right arrow Restenosis
Right arrow Smooth muscle proliferation and differentiation
Right arrow Platelets

(Circulation. 2001;103:1128.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Recombinant Soluble P-Selectin Glycoprotein Ligand-1-Ig Reduces Restenosis Through Inhibition of Platelet-Neutrophil Adhesion After Double Angioplasty in Swine

Jean-Guy Bienvenu, DVM; Jean-François Tanguay, MD; Jean-François Théorêt, MSc; Anjali Kumar, PhD; Robert G. Schaub, PhD; Yahye Merhi, PhD

From the Research Center, Montreal Heart Institute (J.-G.B., J.-F. Tanguay, J-F. Théorêt, Y.M.), the University of Montreal (J.-G.B., J.-F. Tanguay, J-F. Théorêt, Y.M.), Montreal, Quebec, Canada; and Wyeth/Genetics Institute (A.K., R.G.S.), Andover, Mass.

Correspondence to Yahye Merhi, Laboratory of Experimental Pathology, Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec, Canada, H1T 1C8. E-mail merhi{at}icm.umontreal.ca

Background—P-selectin mediates leukocyte recruitment to activated platelets and endothelium through its high-affinity receptor P-selectin glycoprotein ligand-1 (PSGL-1). Platelet and leukocyte activation and binding have been reported after coronary angioplasty and were correlated with restenosis. We investigated the effect of a recombinant soluble PSGL-1 (rPSGL-Ig) on the adhesion of platelets and neutrophils and the development of restenosis after double arterial injury.

Methods and Results—Four weeks after angioplasty of both carotid arteries in pigs, a second angioplasty was performed at the same sites, 15 minutes after a single administration of vehicle or rPSGL-1 (1 mg/kg IV). Animals were euthanized 1 hour, 4 hours, 1 week, or 4 weeks later. Adhesion of autologous 51Cr-platelets and 111In-neutrophils was quantified and histological/morphometric analyses were performed. Although rPSGL-Ig did not affect adherence of these cells 1 hour after injury, it significantly reduced the adhesion of platelets (50% at 4 hours and 85% at 1 week) and neutrophils (50% at 4 hours and 78% at 1 week) to deeply injured arteries. At 4 weeks, the residual lumen was 63% larger in rPSGL-Ig–treated arteries as compared with control arteries (6.1±0.6 versus 3.8±0.1 mm2; P<0.002). The neointimal area was slightly reduced (0.5 in rPSGL-Ig versus 0.7 mm2 in control). The ratio of the external elastic lamina of injured to uninjured reference segments was >1 in treated arteries and <1 in control arteries.

Conclusions—P-selectin antagonism with rPSGL-Ig inhibits early platelet/leukocyte adhesion on injured arteries and reduces restenosis through a positive impact on vascular remodeling. Hence, rPSGL-Ig may have potential in the prevention of restenosis.


Key Words: restenosis • remodeling • glycoproteins • platelets • leukocytes




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Wang, W. Zhang, R. Tang, R. P. Hebbel, M. A. Kowalska, C. Zhang, J. D. Marth, M. Fukuda, C. Zhu, and Y. Huo
Core2 1-6-N-Glucosaminyltransferase-I Deficiency Protects Injured Arteries From Neointima Formation in ApoE-Deficient Mice
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1053 - 1059.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. M. van Gils, J. J. Zwaginga, and P. L. Hordijk
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases
J. Leukoc. Biol., February 1, 2009; 85(2): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Bournazos, J. Rennie, S. P. Hart, K. A.A. Fox, and I. Dransfield
Monocyte Functional Responsiveness After PSGL-1-Mediated Platelet Adhesion Is Dependent on Platelet Activation Status
Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1491 - 1498.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. W. Bedard, V. Clerin, N. Sushkova, B. Tchernychev, T. Antrilli, C. Resmini, J. C. Keith Jr., J. K. Hennan, N. Kaila, S. DeBernardo, et al.
Characterization of the Novel P-Selectin Inhibitor PSI-697 [2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] Quinoline-4-carboxylic acid] in Vitro and in Rodent Models of Vascular Inflammation and Thrombosis
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 497 - 506.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Geraldes, S. Gagnon, S. Hadjadj, Y. Merhi, M. G. Sirois, I. Cloutier, and J.-F. Tanguay
Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: An ER{alpha}-mediated pathway
Cardiovasc Res, August 1, 2006; 71(3): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Wang, X. Zhou, Z. Zhou, N. Mal, L. Fan, M. Zhang, A. M. Lincoff, E. F. Plow, E. J. Topol, and M. S. Penn
Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular Injury
Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1584 - 1589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Costa and D. I. Simon
Molecular Basis of Restenosis and Drug-Eluting Stents
Circulation, May 3, 2005; 111(17): 2257 - 2273.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Martinez, M. Joffraud, S. Giraud, B. Baisse, M. P. Bernimoulin, M. Schapira, and O. Spertini
Regulation of PSGL-1 Interactions with L-selectin, P-selectin, and E-selectin: ROLE OF HUMAN FUCOSYLTRANSFERASE-IV AND -VII
J. Biol. Chem., February 18, 2005; 280(7): 5378 - 5390.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Yanaba, K. Komura, M. Horikawa, Y. Matsushita, K. Takehara, and S. Sato
P-selectin glycoprotein ligand-1 is required for the development of cutaneous vasculitis induced by immune complex deposition
J. Leukoc. Biol., August 1, 2004; 76(2): 374 - 382.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Manka, S. B. Forlow, J. M. Sanders, D. Hurwitz, D. K. Bennett, S. A. Green, K. Ley, and I. J. Sarembock
Critical Role of Platelet P-Selectin in the Response to Arterial Injury in Apolipoprotein-E-Deficient Mice
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1124 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
K Yanaba, K Takehara, and S Sato
Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis
Ann Rheum Dis, May 1, 2004; 63(5): 583 - 587.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. W. Phillips, K. G. Barringhaus, J. M. Sanders, S. E. Hesselbacher, A. C. Czarnik, D. Manka, D. Vestweber, K. Ley, and I. J. Sarembock
Single Injection of P-Selectin or P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Blocks Neointima Formation After Arterial Injury in Apolipoprotein E-Deficient Mice
Circulation, May 6, 2003; 107(17): 2244 - 2249.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. C. Burger and D. D. Wagner
Platelet P-selectin facilitates atherosclerotic lesion development
Blood, April 1, 2003; 101(7): 2661 - 2666.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. J. M. Molenaar, C. C. M. Appeldoorn, S. A. M. de Haas, I. N. Michon, A. Bonnefoy, M. F. Hoylaerts, H. Pannekoek, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen
Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists
Blood, November 15, 2002; 100(10): 3570 - 3577.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Zhou, M. S. Penn, F. Forudi, X. Zhou, K. Tarakji, E. J. Topol, A. M. Lincoff, and K. Wang
Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1598 - 1603.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. J. Shebuski and K. S. Kilgore
Role of Inflammatory Mediators in Thrombogenesis
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 729 - 735.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. C. Barbaux, S. Blankenberg, H. J. Rupprecht, C. Francomme, C. Bickel, G. Hafner, V. Nicaud, J. Meyer, F. Cambien, and L. Tiret
Association Between P-Selectin Gene Polymorphisms and Soluble P-Selectin Levels and Their Relation to Coronary Artery Disease
Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1668 - 1673.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-F. Theoret, J.-G. Bienvenu, A. Kumar, and Y. Merhi
P-Selectin Antagonism with Recombinant P-Selectin Glycoprotein Ligand-1 (rPSGL-Ig) Inhibits Circulating Activated Platelet Binding to Neutrophils Induced by Damaged Arterial Surfaces
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 658 - 664.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Sarma, C. A. Laan, S. Alam, A. Jha, K. A.A. Fox, and I. Dransfield
Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes
Circulation, May 7, 2002; 105(18): 2166 - 2171.
[Abstract] [Full Text] [PDF]